BeOne Medicines (ONC) EBT Growth (1y) (2016 - 2026)
BeOne Medicines (ONC) EBT Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1,140.26% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 71.54% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.15% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 116.44% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 9,460.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,140.26% |
| Dec 31, 2025 | 274.86% |
| Sep 30, 2025 | 249.70% |
| Jun 30, 2025 | 193.99% |
| Mar 31, 2025 | 108.59% |
| Dec 31, 2024 | 75.67% |
| Sep 30, 2024 | -142.86% |
| Jun 30, 2024 | 71.18% |
| Mar 31, 2024 | 27.75% |
| Dec 31, 2023 | 18.61% |
| Sep 30, 2023 | 141.60% |
| Jun 30, 2023 | 34.10% |
| Mar 31, 2023 | 20.01% |
| Dec 31, 2022 | 28.89% |
| Sep 30, 2022 | -27.28% |
| Jun 30, 2022 | -16.03% |
| Mar 31, 2022 | -780.92% |
| Dec 31, 2021 | -25.74% |
| Sep 30, 2021 | 0.45% |
| Jun 30, 2021 | -42.27% |